Aromaxyl 25 - Kalpa Pharmaceuticals

First marketed in 2000 under the brand Aromasin, Exemestane is a steroidal aromatase inhibitor developed by Pharmacia. It differs from nonsteroidal inhibitors by forming a permanent bond with the aromatase enzyme, leading to lasting estrogen suppression. It is mainly prescribed for breast cancer in postmenopausal women who did not respond to tamoxifen. In athletic use, it helps control estrogen-related effects from anabolic steroids. Exemestane became one of the most accessible anti-estrogens globally, supplied typically in 25 mg tablet form.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Aromaxyl 25 by Kalpa Pharmaceuticals, consult with your doctor or healthcare professional.